Gene Editing & CRISPR Therapeutics

Gene editing, particularly CRISPR-Cas technology, has transformed pharmaceutical biotechnology by enabling precise modifications of the genome. This approach allows researchers to target disease-causing genes for therapeutic intervention, offering potential cures for genetic disorders, cancer, and rare diseases. CRISPR applications range from generating disease models to developing personalized gene therapies. Advanced delivery systems, including viral and non-viral vectors, improve the specificity and safety of gene editing. Clinical translation requires careful evaluation of off-target effects, immune responses, and ethical considerations. Integrating CRISPR with other emerging technologies such as induced pluripotent stem cells (iPSCs) and organoids further enhances the potential for patient-specific therapeutics. Ongoing research is exploring multiplexed gene editing, base editing, and prime editing to expand precision medicine applications. Regulatory frameworks are evolving to accommodate these innovations while ensuring safety and efficacy. With growing investment in gene therapy startups and increasing collaborations between academia and industry, CRISPR-based therapeutics are poised to redefine treatment paradigms in oncology, rare diseases, and beyond. The combination of technological innovation, translational research, and ethical oversight positions gene editing as a central pillar in next-generation pharmaceutical biotechnology.

    Related Conference of Gene Editing & CRISPR Therapeutics

    January 29-30, 2026

    19th World Drug Delivery Summit

    Paris, France
    February 10-11, 2026

    40th World Congress on Pharmacology and Therapeutics

    Barcelona, Spain
    February 23-24, 2026

    3rd World Congress on Biologics and Biosimilars

    London, UK
    March 23-24, 2026

    36th Annual European Pharma Congress

    London, UK
    March 24-25, 2026

    11th International Conference on Future Pharma and Innovations

    Amsterdam, Netherlands
    April 16-17, 2026

    19th European Biosimilars Congress

    Rome, Italy
    April 27-28, 2026

    9th European Biopharma Congress

    Paris, Aland Islands
    May 28-29, 2026

    3rd International Conference on Pharmacognosy

    Madrid, Spain
    July 27-28, 2026

    39th World Congress on Pharmacology

    Rome, Italy
    September 24-25, 2026

    6th World Congress on Rare Diseases & Orphan Drugs

    Paris, France

    Gene Editing & CRISPR Therapeutics Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in